The REPAIR Impact Fund has opened its second investment proposal round to European life science companies targeting antimicrobial resistance. Companies are invited to submit…
BEAM Alliance has released a new position paper on PUSH Incentives called ‘Supporting financial investments on R&D to de-risk antimicrobial development”. Key messages Antimicrobial…
The AMR Centre has received £2.3 million to support the expansion of its pipeline of new drugs to treat drug-resistant infections. Based at Alderley…